Skip to main content
Advanced Enzyme Technologies Limited logo

Advanced Enzyme Technologies Limited — Investor Relations & Filings

Ticker · ADVENZYMES ISIN · INE837H01020 LEI · 335800PWJRERMBTUUV90 BSE.NS Manufacturing
Open in API
Filings indexed 938 across all filing types
Latest filing 2024-04-08 Regulatory Filings
Country IN India
Listing BSE.NS ADVENZYMES

About Advanced Enzyme Technologies Limited

https://www.advancedenzymes.com/

Advanced Enzyme Technologies Limited is a research-driven company specializing in the development, manufacturing, and marketing of proprietary enzyme products and probiotics. The company operates across the entire enzyme value chain, from research and development to commercial-scale production. Its diverse portfolio serves multiple sectors, including human nutrition, animal nutrition, and industrial processing. Key applications encompass food and beverage production, dietary supplements, animal feed additives, and various industrial processes such as textiles, detergents, and pulp and paper manufacturing. With a focus on biotechnology and sustainable solutions, the firm leverages its extensive R&D capabilities to provide customized enzyme formulations. The company maintains a global footprint, supplying specialized biological solutions to a broad international client base.

Recent filings

Filing Released Lang Actions
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate issued under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, confirming dematerialisation activities for the quarter ended March 31, 2024. It is a compliance certificate from the Registrar and Transfer Agent to the company and stock exchanges. The document does not contain financial statements or detailed financial data, nor is it an announcement of a report publication. It is primarily a regulatory compliance certificate related to securities dematerialisation. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for regulatory announcements and compliance documents that do not fit other specific categories.
2024-04-08 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2024-04-08 English
Change in Director(s)
Board/Management Information Classification · 100% confidence The document is a formal notification addressed to stock exchanges regarding the cessation of an Independent Director due to completion of his second term. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, which pertains to disclosures about changes in board composition. The content focuses on management/board changes and does not contain financial data, earnings, or report publication information. The document length is short (2235 characters), and it is clearly an announcement of a board change rather than a report or financial filing. Therefore, the appropriate classification is Board/Management Information (MANG).
2024-03-30 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a short notice informing stock exchanges about the closure of the trading window due to upcoming financial results announcement. It references regulatory compliance with insider trading regulations and specifies dates for the trading window closure. The document does not contain any financial data, detailed report content, or results itself. It is an announcement related to trading restrictions ahead of financial disclosures, not a financial report or earnings release. Given the short length (1166 characters) and nature of the content, it fits best as a Regulatory Filing (RNS), which covers miscellaneous regulatory announcements that do not fit other categories.
2024-03-29 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice informing stock exchanges about a scheduled analyst/institutional investor meeting. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and provides details of the meeting date and participants. There is no financial data, no detailed report, no voting results, no management discussion, or other substantive content typical of financial reports. The document is essentially an announcement of an upcoming investor meeting, not the meeting materials or transcript itself. Given the short length (1254 characters) and the nature of the content, it fits best as a Regulatory Filing (RNS), which is a fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-03-15 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice informing stock exchanges about scheduled analyst and institutional investor meetings. It references compliance with SEBI Listing Obligations and Disclosure Requirements but does not contain any financial data, detailed presentations, or reports. The document is essentially an announcement of upcoming meetings rather than the meetings' content or a report. Given its brevity (1434 characters) and nature as an announcement, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-03-15 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.